Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

IOSP vs LIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IOSP
Innospec Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$1.94B
5Y Perf.+0.8%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$231.88B
5Y Perf.+148.0%

IOSP vs LIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IOSP logoIOSP
LIN logoLIN
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$1.94B$231.88B
Revenue (TTM)$1.78B$34.66B
Net Income (TTM)$117M$7.13B
Gross Margin27.7%46.0%
Operating Margin8.7%28.8%
Forward P/E15.7x28.1x
Total Debt$90M$26.99B
Cash & Equiv.$293M$5.06B

IOSP vs LINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IOSP
LIN
StockMay 20May 26Return
Innospec Inc. (IOSP)100100.8+0.8%
Linde plc (LIN)100248.0+148.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: IOSP vs LIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Innospec Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
IOSP
Innospec Inc.
The Income Pick

IOSP is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 12 yrs, beta 0.70, yield 2.2%
  • Lower volatility, beta 0.70, Low D/E 6.3%, current ratio 2.79x
  • PEG 0.49 vs LIN's 1.11
Best for: income & stability and sleep-well-at-night
LIN
Linde plc
The Growth Play

LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
  • 379.1% 10Y total return vs IOSP's 83.5%
  • 3.0% revenue growth vs IOSP's -3.7%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthLIN logoLIN3.0% revenue growth vs IOSP's -3.7%
ValueIOSP logoIOSPLower P/E (15.7x vs 28.1x), PEG 0.49 vs 1.11
Quality / MarginsLIN logoLIN20.6% margin vs IOSP's 6.6%
Stability / SafetyLIN logoLINBeta 0.24 vs IOSP's 0.70
DividendsIOSP logoIOSP2.2% yield, 12-year raise streak, vs LIN's 1.2%
Momentum (1Y)LIN logoLIN+11.9% vs IOSP's -13.4%
Efficiency (ROA)LIN logoLIN8.3% ROA vs IOSP's 6.4%, ROIC 11.3% vs 10.7%

IOSP vs LIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IOSPInnospec Inc.
FY 2025
Fuel Specialties
39.5%$702M
Performance Chemicals
38.3%$681M
Oilfield Services
22.2%$395M
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B

IOSP vs LIN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLINLAGGINGIOSP

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 5 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 19.5x IOSP's $1.8B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to IOSP's 6.6%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
RevenueTrailing 12 months$1.8B$34.7B
EBITDAEarnings before interest/tax$198M$12.1B
Net IncomeAfter-tax profit$117M$7.1B
Free Cash FlowCash after capex$88M$5.1B
Gross MarginGross profit ÷ Revenue+27.7%+46.0%
Operating MarginEBIT ÷ Revenue+8.7%+28.8%
Net MarginNet income ÷ Revenue+6.6%+20.6%
FCF MarginFCF ÷ Revenue+4.9%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year-2.4%+8.2%
EPS Growth (YoY)Latest quarter vs prior year+167.7%+13.4%
LIN leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

IOSP leads this category, winning 7 of 7 comparable metrics.

At 16.7x trailing earnings, IOSP trades at a 51% valuation discount to LIN's 34.3x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.52x vs LIN's 1.35x — a lower PEG means you pay less per unit of expected earnings growth.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
Market CapShares × price$1.9B$231.9B
Enterprise ValueMkt cap + debt − cash$1.7B$253.8B
Trailing P/EPrice ÷ TTM EPS16.74x34.30x
Forward P/EPrice ÷ next-FY EPS est.15.66x28.12x
PEG RatioP/E ÷ EPS growth rate0.52x1.35x
EV / EBITDAEnterprise value multiple8.44x19.99x
Price / SalesMarket cap ÷ Revenue1.09x6.82x
Price / BookPrice ÷ Book value/share1.38x5.90x
Price / FCFMarket cap ÷ FCF22.02x45.56x
IOSP leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

LIN leads this category, winning 4 of 7 comparable metrics.

LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $8 for IOSP. IOSP carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
ROE (TTM)Return on equity+8.2%+17.8%
ROA (TTM)Return on assets+6.4%+8.3%
ROICReturn on invested capital+10.7%+11.3%
ROCEReturn on capital employed+11.0%+13.0%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.06x0.68x
Net DebtTotal debt minus cash-$203M$21.9B
Cash & Equiv.Liquid assets$293M$5.1B
Total DebtShort + long-term debt$90M$27.0B
Interest CoverageEBIT ÷ Interest expense34.52x
LIN leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

LIN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LIN five years ago would be worth $18,055 today (with dividends reinvested), compared to $8,533 for IOSP. Over the past 12 months, LIN leads with a +11.9% total return vs IOSP's -13.4%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.2% vs IOSP's -6.0% — a key indicator of consistent wealth creation.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
YTD ReturnYear-to-date+2.5%+17.0%
1-Year ReturnPast 12 months-13.4%+11.9%
3-Year ReturnCumulative with dividends-16.9%+41.2%
5-Year ReturnCumulative with dividends-14.7%+80.6%
10-Year ReturnCumulative with dividends+83.5%+379.1%
CAGR (3Y)Annualised 3-year return-6.0%+12.2%
LIN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than IOSP's 0.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.0% from its 52-week high vs IOSP's 81.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
Beta (5Y)Sensitivity to S&P 5000.70x0.24x
52-Week HighHighest price in past year$95.55$521.28
52-Week LowLowest price in past year$65.58$387.78
% of 52W HighCurrent price vs 52-week peak+81.8%+96.0%
RSI (14)Momentum oscillator 0–10055.545.6
Avg Volume (50D)Average daily shares traded225K2.3M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

IOSP leads this category, winning 2 of 2 comparable metrics.

Wall Street rates IOSP as "Hold" and LIN as "Buy". Consensus price targets imply 47.1% upside for IOSP (target: $115) vs 7.9% for LIN (target: $540). For income investors, IOSP offers the higher dividend yield at 2.17% vs LIN's 1.20%.

MetricIOSP logoIOSPInnospec Inc.LIN logoLINLinde plc
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$115.00$539.71
# AnalystsCovering analysts928
Dividend YieldAnnual dividend ÷ price+2.2%+1.2%
Dividend StreakConsecutive years of raises126
Dividend / ShareAnnual DPS$1.70$6.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.0%
IOSP leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IOSP leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallLinde plc (LIN)Leads 4 of 6 categories
Loading custom metrics...

IOSP vs LIN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is IOSP or LIN a better buy right now?

For growth investors, Linde plc (LIN) is the stronger pick with 3.

0% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). Innospec Inc. (IOSP) offers the better valuation at 16. 7x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Linde plc (LIN) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IOSP or LIN?

On trailing P/E, Innospec Inc.

(IOSP) is the cheapest at 16. 7x versus Linde plc at 34. 3x. On forward P/E, Innospec Inc. is actually cheaper at 15. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 49x versus Linde plc's 1. 11x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — IOSP or LIN?

Over the past 5 years, Linde plc (LIN) delivered a total return of +80.

6%, compared to -14. 7% for Innospec Inc. (IOSP). Over 10 years, the gap is even starker: LIN returned +376. 9% versus IOSP's +83. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IOSP or LIN?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Innospec Inc. 's 0. 70β — meaning IOSP is approximately 190% more volatile than LIN relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 6% versus 68% for Linde plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — IOSP or LIN?

By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.

0% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IOSP or LIN?

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus 6. 6% for Innospec Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 8. 8% for IOSP. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IOSP or LIN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 49x versus Linde plc's 1. 11x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Innospec Inc. (IOSP) trades at 15. 7x forward P/E versus 28. 1x for Linde plc — 12. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 47. 1% to $115. 00.

08

Which pays a better dividend — IOSP or LIN?

All stocks in this comparison pay dividends.

Innospec Inc. (IOSP) offers the highest yield at 2. 2%, versus 1. 2% for Linde plc (LIN).

09

Is IOSP or LIN better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, IOSP: +83. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IOSP and LIN?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IOSP is a small-cap deep-value stock; LIN is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

IOSP

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IOSP and LIN on the metrics below

Revenue Growth>
%
(IOSP: -2.4% · LIN: 8.2%)
Net Margin>
%
(IOSP: 6.6% · LIN: 20.6%)
P/E Ratio<
x
(IOSP: 16.7x · LIN: 34.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.